213 related articles for article (PubMed ID: 33744203)
1. Salvage transoral robotic surgery in early-stage oropharyngeal recurrence.
Asairinachan A; O'Duffy F; Fua T; Magarey MJR; Dixon BJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jul; 132(1):18-25. PubMed ID: 33744203
[TBL] [Abstract][Full Text] [Related]
2. Salvage Transoral Robotic Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma: A Single Institution Experience.
Dabas S; Dewan A; Ranjan R; Dewan AK; Shukla H; Sinha R
Asian Pac J Cancer Prev; 2015; 16(17):7627-32. PubMed ID: 26625773
[TBL] [Abstract][Full Text] [Related]
3. Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches.
White H; Ford S; Bush B; Holsinger FC; Moore E; Ghanem T; Carroll W; Rosenthal E; Sweeny L; Magnuson JS
JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):773-8. PubMed ID: 23949352
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
[TBL] [Abstract][Full Text] [Related]
5. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
6. Salvage transoral robotic surgery in recurrent oropharyngeal carcinoma: a single-center retrospective study.
Ansarin M; Pietrobon G; Tagliabue M; Mossinelli C; Ruju F; Maffini F; Rocca MC; Alterio D; Simon C; Zorzi SF
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3167-3177. PubMed ID: 38546850
[TBL] [Abstract][Full Text] [Related]
7. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
[TBL] [Abstract][Full Text] [Related]
8. Feeding Tube Placement Following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma.
Feng AL; Holcomb AJ; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Holman A; Kammer RE; Goldsmith TA; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
Otolaryngol Head Neck Surg; 2022 Apr; 166(4):696-703. PubMed ID: 34154449
[TBL] [Abstract][Full Text] [Related]
9. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
10. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for gastrostomy tube dependence in transoral robotic surgery patients.
Philips R; Topf MC; Vimawala S; Luginbuhl A; Curry JM; Cognetti DM
Am J Otolaryngol; 2022; 43(1):103175. PubMed ID: 34418824
[TBL] [Abstract][Full Text] [Related]
12. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.
Sharma A; Patel S; Baik FM; Mathison G; Pierce BH; Khariwala SS; Yueh B; Schwartz SM; Méndez E
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):691-7. PubMed ID: 27347780
[TBL] [Abstract][Full Text] [Related]
13. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R
Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433
[TBL] [Abstract][Full Text] [Related]
14. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Lörincz BB; Möckelmann N; Busch CJ; Knecht R
Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
[TBL] [Abstract][Full Text] [Related]
16. Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma.
Heah H; Goepfert RP; Hutcheson KA; Garden AS; Gunn GB; Fuller CD; Lewin JS; Kupferman ME; Holsinger FC; Hessel AC; Gross ND
Head Neck; 2018 Nov; 40(11):2507-2513. PubMed ID: 30102824
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Free Flap Reconstruction Following Salvage Robotic-Assisted Resection of Recurrent and Residual Oropharyngeal Cancer in 3 Patients.
Williamson A; Haywood M; Awad Z
Ear Nose Throat J; 2021 Dec; 100(10_suppl):1113S-1118S. PubMed ID: 32608257
[TBL] [Abstract][Full Text] [Related]
18. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.
Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991
[TBL] [Abstract][Full Text] [Related]
19. Oncological outcome following initiation of treatment for stage III and IV HPV negative oropharyngeal cancers with transoral robotic surgery (TORS).
Dabas S; Gupta K; Sharma AK; Shukla H; Ranjan R; Sharma DK
Eur J Surg Oncol; 2019 Nov; 45(11):2137-2142. PubMed ID: 31239156
[TBL] [Abstract][Full Text] [Related]
20. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
